Skip to main content
Clinical Trials/NL-OMON51712
NL-OMON51712
Not yet recruiting
Not Applicable

The COllaborative Neonatal NEtwork for the first CPAM Trial, the CONNECT - CONNECT trial

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Congenital lung abnormality
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
70
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- Lesion detected during routine prenatal ultrasound screening
  • \- Delivery at term: gestational age \>\=37 weeks
  • \- Birthweight \> \-2SD or \>P10
  • \- Asymptomatic at birth defined as no prolonged respiratory distress or oxygen
  • support (\< 24 hours)
  • \- Asymptomatic up to the moment of inclusion
  • \- Confirmation of CPAM on postnatal chest CT\-scan at 3\-9 months of age,
  • according to structured report form
  • \- Unilateral lesion occupying no more than one lung lobe as assessed on chest
  • CT\-scan at 3\-9 months of age

Exclusion Criteria

  • \- Bilateral lesion
  • \- Development of symptoms before randomization, considered by treating
  • physician as caused by CPAM with reasonable certainty
  • \- Complicated pregnancy defined as (pre\-)eclampsia, pregnancy diabetes in
  • mother, foetal hydrops or severe polyhydramnios on prenatal ultrasound
  • \- Syndrome associated anomalies on genetic analysis confirmed by genetic expert
  • \- Major associated malformations. Anomalies include cardiac malformations
  • requiring surgical correction or follow\-up by a paediatric cardiologist,
  • congenital malformations requiring major surgical intervention, and anomalies
  • that affect normal lung growth and development.

Outcomes

Primary Outcomes

Not specified

Similar Trials